These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28858767)

  • 1. Discovery of new MD2-targeted anti-inflammatory compounds for the treatment of sepsis and acute lung injury.
    Chen G; Xiao B; Chen L; Bai B; Zhang Y; Xu Z; Fu L; Liu Z; Li X; Zhao Y; Liang G
    Eur J Med Chem; 2017 Oct; 139():726-740. PubMed ID: 28858767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of caffeic acid phenethyl ester derivatives as novel myeloid differentiation protein 2 inhibitors for treatment of acute lung injury.
    Chen L; Jin Y; Chen H; Sun C; Fu W; Zheng L; Lu M; Chen P; Chen G; Zhang Y; Liu Z; Wang Y; Song Z; Liang G
    Eur J Med Chem; 2018 Jan; 143():361-375. PubMed ID: 29202400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a New Inhibitor of Myeloid Differentiation 2 from Cinnamamide Derivatives with Anti-Inflammatory Activity in Sepsis and Acute Lung Injury.
    Chen G; Zhang Y; Liu X; Fang Q; Wang Z; Fu L; Liu Z; Wang Y; Zhao Y; Li X; Liang G
    J Med Chem; 2016 Mar; 59(6):2436-51. PubMed ID: 26937738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization and anti-inflammatory evaluation of methyl gallate derivatives as a myeloid differentiation protein 2 inhibitor.
    Qiu Y; Xiao Z; Wang Y; Zhang D; Zhang W; Wang G; Chen W; Liang G; Li X; Zhang Y; Liu Z
    Bioorg Med Chem; 2019 Oct; 27(20):115049. PubMed ID: 31466835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chalcone derivatives ameliorate lipopolysaccharide-induced acute lung injury and inflammation by targeting MD2.
    Zhang YL; Zhang WX; Yan JQ; Tang YL; Jia WJ; Xu ZW; Xu MJ; Chattipakorn N; Wang Y; Feng JP; Liu ZG; Liang G
    Acta Pharmacol Sin; 2022 Jan; 43(1):76-85. PubMed ID: 34480112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting myeloid differentiation protein 2 by the new chalcone L2H21 protects LPS-induced acute lung injury.
    Zhang Y; Xu T; Wu B; Chen H; Pan Z; Huang Y; Mei L; Dai Y; Liu X; Shan X; Liang G
    J Cell Mol Med; 2017 Apr; 21(4):746-757. PubMed ID: 27860279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arachidonic acid inhibits inflammatory responses by binding to myeloid differentiation factor-2 (MD2) and preventing MD2/toll-like receptor 4 signaling activation.
    Zhang Y; Chen H; Zhang W; Cai Y; Shan P; Wu D; Zhang B; Liu H; Khan ZA; Liang G
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165683. PubMed ID: 31953218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin Analog L48H37 Prevents Lipopolysaccharide-Induced TLR4 Signaling Pathway Activation and Sepsis via Targeting MD2.
    Wang Y; Shan X; Dai Y; Jiang L; Chen G; Zhang Y; Wang Z; Dong L; Wu J; Guo G; Liang G
    J Pharmacol Exp Ther; 2015 Jun; 353(3):539-50. PubMed ID: 25862641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New MD2 inhibitors derived from curcumin with improved anti-inflammatory activity.
    Zhang Y; Liu Z; Wu J; Bai B; Chen H; Xiao Z; Chen L; Zhao Y; Lum H; Wang Y; Zhang H; Liang G
    Eur J Med Chem; 2018 Mar; 148():291-305. PubMed ID: 29466778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of new MD2 inhibitor from chalcone derivatives with anti-inflammatory effects in LPS-induced acute lung injury.
    Zhang Y; Wu J; Ying S; Chen G; Wu B; Xu T; Liu Z; Liu X; Huang L; Shan X; Dai Y; Liang G
    Sci Rep; 2016 Apr; 6():25130. PubMed ID: 27118147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of myeloid differentiation factor 2 by baicalein protects against acute lung injury.
    Chen H; Zhang Y; Zhang W; Liu H; Sun C; Zhang B; Bai B; Wu D; Xiao Z; Lum H; Zhou J; Chen R; Liang G
    Phytomedicine; 2019 Oct; 63():152997. PubMed ID: 31254764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of 2-amino-4-phenylthiazole analogues to disrupt myeloid differentiation factor 88 and prevent inflammatory responses in acute lung injury.
    Chen L; Chen H; Chen P; Zhang W; Wu C; Sun C; Luo W; Zheng L; Liu Z; Liang G
    Eur J Med Chem; 2019 Jan; 161():22-38. PubMed ID: 30342423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of hesperetin on lipopolysaccharide-induced acute lung injury by targeting MD2.
    Ye J; Guan M; Lu Y; Zhang D; Li C; Li Y; Zhou C
    Eur J Pharmacol; 2019 Jun; 852():151-158. PubMed ID: 30807747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress in the discovery of myeloid differentiation 2 (MD2) modulators for inflammatory diseases.
    Chen L; Fu W; Zheng L; Wang Y; Liang G
    Drug Discov Today; 2018 Jun; 23(6):1187-1202. PubMed ID: 29330126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L6H9 attenuates LPS-induced acute lung injury in rats through targeting MD2.
    Wu P; Yan H; Qi J; Jia W; Zhang W; Yao D; Ding C; Zhang Y; Chen M; Cai X
    Drug Dev Res; 2020 Feb; 81(1):85-92. PubMed ID: 31693211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flavokawain B alleviates LPS-induced acute lung injury via targeting myeloid differentiation factor 2.
    Luo W; Yang LB; Qian CC; Ma B; Manjengwa GM; Miao XM; Wang J; Hu CH; Jin B; Zhang LX; Zheng C; Liang G; Wang Y
    Acta Pharmacol Sin; 2022 Jul; 43(7):1758-1768. PubMed ID: 34737421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of novel 2-sulfonylindoles as potential anti-inflammatory therapeutic agents for treatment of acute lung injury.
    Xia Q; Bao X; Sun C; Wu D; Rong X; Liu Z; Gu Y; Zhou J; Liang G
    Eur J Med Chem; 2018 Dec; 160():120-132. PubMed ID: 30326372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis, and Structure-Activity Relationship Analysis of Thiazolo[3,2-a]pyrimidine Derivatives with Anti-inflammatory Activity in Acute Lung Injury.
    Chen L; Jin Y; Fu W; Xiao S; Feng C; Fang B; Gu Y; Li C; Zhao Y; Liu Z; Liang G
    ChemMedChem; 2017 Jul; 12(13):1022-1032. PubMed ID: 28503918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardamonin inhibits LPS-induced inflammatory responses and prevents acute lung injury by targeting myeloid differentiation factor 2.
    Yang L; Luo W; Zhang Q; Hong S; Wang Y; Samorodov AV; Chattipakorn N; Pavlov VN; Liang G
    Phytomedicine; 2021 Dec; 93():153785. PubMed ID: 34638032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of 3-(Indol-5-yl)-indazole Derivatives as Novel Myeloid Differentiation Protein 2/Toll-like Receptor 4 Antagonists for Treatment of Acute Lung Injury.
    Liu Z; Chen L; Yu P; Zhang Y; Fang B; Wu C; Luo W; Chen X; Li C; Liang G
    J Med Chem; 2019 Jun; 62(11):5453-5469. PubMed ID: 30998353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.